COMPLETE TEST BANK FOR
Lilley's Pharmacology for Canadian Health Care Practice 4th Edition
by Kara Sealoc (ALL CHAPTERS 1-58 & ANSWERS)
,TABLE OF CONTENTS
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY ........................................................... 4
CHAPTER 02: PHARMACOLOGICAL PRINCIPLES ............................................................................................ 9
CHAPTER 03: LEGAL AND ETHICAL CONSIDERATIONS ................................................................................ 14
CHAPTER 04: PATIENT-FOCUSED CONSIDERATIONS................................................................................... 19
CHAPTER 05: GENE THERAPY AND PHARMACOGENOMICS ....................................................................... 28
CHAPTER 06: MEDICATION ERRORS: PREVENTING AND RESPONDING ...................................................... 31
CHAPTER 07: PATIENT EDUCATION AND DRUG THERAPY .......................................................................... 34
CHAPTER 08: OVER-THE-COUNTER DRUGS AND NATURAL HEALTH PRODUCTS........................................ 38
CHAPTER 09: VITAMINS AND MINERALS .................................................................................................... 42
CHAPTER 10: PRINCIPLES OF DRUG ADMINISTRATION .............................................................................. 46
CHAPTER 11: ANALGESIC DRUGS ................................................................................................................ 56
CHAPTER 12: GENERAL AND LOCAL ANAESTHETICS ................................................................................... 63
CHAPTER 13: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............................... 68
CHAPTER 14: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ....................................... 73
CHAPTER 15: ANTIEPILEPTIC DRUGS........................................................................................................... 78
CHAPTER 16: ANTIPARKINSONIAN DRUGS ................................................................................................. 84
CHAPTER 17: PSYCHOTHERAPEUTIC DRUGS ............................................................................................... 88
CHAPTER 18: SUBSTANCE MISUSE .............................................................................................................. 96
CHAPTER 19: ADRENERGIC DRUGS ........................................................................................................... 101
CHAPTER 20: ADRENERGIC-BLOCKING DRUGS ......................................................................................... 107
CHAPTER 21: CHOLINERGIC DRUGS .......................................................................................................... 112
CHAPTER 22: CHOLINERGIC-BLOCKING DRUGS ........................................................................................ 117
CHAPTER 23: ANTIHYPERTENSIVE DRUGS ................................................................................................ 122
CHAPTER 24: ANTIANGINAL DRUGS ......................................................................................................... 128
CHAPTER 25: HEART FAILURE DRUGS ....................................................................................................... 134
CHAPTER 26: ANTIDYSRHYTHMIC DRUGS ................................................................................................. 140
CHAPTER 27: COAGULATION MODIFIER DRUGS ....................................................................................... 145
CHAPTER 28: ANTILIPEMIC DRUGS ........................................................................................................... 150
CHAPTER 29: DIURETIC DRUGS ................................................................................................................. 157
CHAPTER 30: FLUIDS AND ELECTROLYTES ................................................................................................ 162
CHAPTER 31: PITUITARY DRUGS ............................................................................................................... 168
CHAPTER 32: THYROID AND ANTITHYROID DRUGS .................................................................................. 173
,CHAPTER 33: ANTIDIABETIC DRUGS ......................................................................................................... 179
CHAPTER 34: ADRENAL DRUGS ................................................................................................................. 186
CHAPTER 35: WOMEN’S HEALTH DRUGS.................................................................................................. 190
CHAPTER 36: MEN’S HEALTH DRUGS ........................................................................................................ 198
CHAPTER 37: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ...................... 203
CHAPTER 38: RESPIRATORY DRUGS .......................................................................................................... 208
CHAPTER 39: ACID-CONTROLLING DRUGS ................................................................................................ 213
CHAPTER 40: ANTIDIARRHEAL DRUGS AND LAXATIVES ........................................................................... 219
CHAPTER 41: ANTIEMETIC AND ANTINAUSEA DRUGS.............................................................................. 225
CHAPTER 42: NUTRITIONAL SUPPLEMENTS.............................................................................................. 229
CHAPTER 43: ANTIBIOTICS PART 1: SULFONAMIDES, PENICILLINS, CEPHALOSPORINS, MACROLIDES, AND
TETRACYCLINES ......................................................................................................................................... 233
CHAPTER 44: ANTIBIOTICS PART 2: AMINOGLYCOSIDES, FLUOROQUINOLONES, AND OTHER DRUGS ... 239
CHAPTER 45: ANTIVIRAL DRUGS ............................................................................................................... 243
CHAPTER 46: ANTITUBERCULAR DRUGS ................................................................................................... 249
CHAPTER 47: ANTIFUNGAL DRUGS ........................................................................................................... 255
CHAPTER 48: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ....................................... 260
CHAPTER 49: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ................................................................. 265
CHAPTER 50: IMMUNOSUPPRESSANT DRUGS.......................................................................................... 270
CHAPTER 51: IMMUNIZING DRUGS AND PANDEMIC PREPAREDNESS ..................................................... 274
CHAPTER 52: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS280
CHAPTER 53: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC AND MISCELLANEOUS DRUGS
.................................................................................................................................................................. 286
CHAPTER 54: BIOLOGICAL RESPONSE–MODIFYING DRUGS AND ANTIRHEUMATIC DRUGS .................... 293
CHAPTER 55: ANEMIA DRUGS................................................................................................................... 299
CHAPTER 56: DERMATOLOGICAL DRUGS ................................................................................................. 305
CHAPTER 57: OPHTHALMIC DRUGS .......................................................................................................... 311
CHAPTER 58: OTIC DRUGS......................................................................................................................... 317
, CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY
MULTIPLE CHOICE
1. WHICH IS A JUDGEMENT ABOUT A PARTICULAR PATIENT’S POTENTIAL NEED OR PROBLEM?
A. A GOAL
B. AN ASSESSMENT
C. SUBJECTIVE DATA
D. A NURSING DIAGNOSIS
ANS:D
NURSING DIAGNOSIS IS THE PHASE OF THE NURSING PROCESS DURING WHICH A CLINICAL JUDGEMENT
IS MADE ABOUT HOW A PATIENT RESPONDS TO HEATH CONDITIONS AND LIFE PROCESSES OR
VULNERABILITY FOR THAT RESPONSE.
DIF: COGNITIVE LEVEL: KNOWLEDGE
2. THE PATIENT IS TO RECEIVE ORAL FUROSEMIDE (LASIX) EVERY DAY; HOWEVER, BECAUSE THE
PATIENT IS UNABLE TO SWALLOW, HE CANNOT TAKE MEDICATION ORALLY, AS ORDERED. THE NURSE
NEEDS TO CONTACT THE PHYSICIAN. WHAT TYPE OF PROBLEM IS THIS?
A. A “RIGHT TIME” PROBLEM
B. A “RIGHT DOSE” PROBLEM
C. A “RIGHT ROUTE” PROBLEM
D. A “RIGHT MEDICATION” PROBLEM
ANS:C
THIS IS A “RIGHT ROUTE” PROBLEM: THE NURSE CANNOT ASSUME THE ROUTE AND MUST CLARIFY THE
ROUTE WITH THE PRESCRIBER. THIS IS NOT A “RIGHT TIME” PROBLEM BECAUSE THE ORDERED
FREQUENCY HAS NOT CHANGED. THIS IS NOT A “RIGHT DOSE” PROBLEM BECAUSE THE DOSE IS NOT
RELATED TO AN INABILITY TO SWALLOW. THIS IS NOT A “RIGHT MEDICATION” PROBLEM BECAUSE THE
MEDICATION ORDERED WILL NOT CHANGE, JUST THE ROUTE.
DIF: COGNITIVE LEVEL: APPLICATION
Lilley's Pharmacology for Canadian Health Care Practice 4th Edition
by Kara Sealoc (ALL CHAPTERS 1-58 & ANSWERS)
,TABLE OF CONTENTS
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY ........................................................... 4
CHAPTER 02: PHARMACOLOGICAL PRINCIPLES ............................................................................................ 9
CHAPTER 03: LEGAL AND ETHICAL CONSIDERATIONS ................................................................................ 14
CHAPTER 04: PATIENT-FOCUSED CONSIDERATIONS................................................................................... 19
CHAPTER 05: GENE THERAPY AND PHARMACOGENOMICS ....................................................................... 28
CHAPTER 06: MEDICATION ERRORS: PREVENTING AND RESPONDING ...................................................... 31
CHAPTER 07: PATIENT EDUCATION AND DRUG THERAPY .......................................................................... 34
CHAPTER 08: OVER-THE-COUNTER DRUGS AND NATURAL HEALTH PRODUCTS........................................ 38
CHAPTER 09: VITAMINS AND MINERALS .................................................................................................... 42
CHAPTER 10: PRINCIPLES OF DRUG ADMINISTRATION .............................................................................. 46
CHAPTER 11: ANALGESIC DRUGS ................................................................................................................ 56
CHAPTER 12: GENERAL AND LOCAL ANAESTHETICS ................................................................................... 63
CHAPTER 13: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............................... 68
CHAPTER 14: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ....................................... 73
CHAPTER 15: ANTIEPILEPTIC DRUGS........................................................................................................... 78
CHAPTER 16: ANTIPARKINSONIAN DRUGS ................................................................................................. 84
CHAPTER 17: PSYCHOTHERAPEUTIC DRUGS ............................................................................................... 88
CHAPTER 18: SUBSTANCE MISUSE .............................................................................................................. 96
CHAPTER 19: ADRENERGIC DRUGS ........................................................................................................... 101
CHAPTER 20: ADRENERGIC-BLOCKING DRUGS ......................................................................................... 107
CHAPTER 21: CHOLINERGIC DRUGS .......................................................................................................... 112
CHAPTER 22: CHOLINERGIC-BLOCKING DRUGS ........................................................................................ 117
CHAPTER 23: ANTIHYPERTENSIVE DRUGS ................................................................................................ 122
CHAPTER 24: ANTIANGINAL DRUGS ......................................................................................................... 128
CHAPTER 25: HEART FAILURE DRUGS ....................................................................................................... 134
CHAPTER 26: ANTIDYSRHYTHMIC DRUGS ................................................................................................. 140
CHAPTER 27: COAGULATION MODIFIER DRUGS ....................................................................................... 145
CHAPTER 28: ANTILIPEMIC DRUGS ........................................................................................................... 150
CHAPTER 29: DIURETIC DRUGS ................................................................................................................. 157
CHAPTER 30: FLUIDS AND ELECTROLYTES ................................................................................................ 162
CHAPTER 31: PITUITARY DRUGS ............................................................................................................... 168
CHAPTER 32: THYROID AND ANTITHYROID DRUGS .................................................................................. 173
,CHAPTER 33: ANTIDIABETIC DRUGS ......................................................................................................... 179
CHAPTER 34: ADRENAL DRUGS ................................................................................................................. 186
CHAPTER 35: WOMEN’S HEALTH DRUGS.................................................................................................. 190
CHAPTER 36: MEN’S HEALTH DRUGS ........................................................................................................ 198
CHAPTER 37: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ...................... 203
CHAPTER 38: RESPIRATORY DRUGS .......................................................................................................... 208
CHAPTER 39: ACID-CONTROLLING DRUGS ................................................................................................ 213
CHAPTER 40: ANTIDIARRHEAL DRUGS AND LAXATIVES ........................................................................... 219
CHAPTER 41: ANTIEMETIC AND ANTINAUSEA DRUGS.............................................................................. 225
CHAPTER 42: NUTRITIONAL SUPPLEMENTS.............................................................................................. 229
CHAPTER 43: ANTIBIOTICS PART 1: SULFONAMIDES, PENICILLINS, CEPHALOSPORINS, MACROLIDES, AND
TETRACYCLINES ......................................................................................................................................... 233
CHAPTER 44: ANTIBIOTICS PART 2: AMINOGLYCOSIDES, FLUOROQUINOLONES, AND OTHER DRUGS ... 239
CHAPTER 45: ANTIVIRAL DRUGS ............................................................................................................... 243
CHAPTER 46: ANTITUBERCULAR DRUGS ................................................................................................... 249
CHAPTER 47: ANTIFUNGAL DRUGS ........................................................................................................... 255
CHAPTER 48: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ....................................... 260
CHAPTER 49: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ................................................................. 265
CHAPTER 50: IMMUNOSUPPRESSANT DRUGS.......................................................................................... 270
CHAPTER 51: IMMUNIZING DRUGS AND PANDEMIC PREPAREDNESS ..................................................... 274
CHAPTER 52: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS280
CHAPTER 53: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC AND MISCELLANEOUS DRUGS
.................................................................................................................................................................. 286
CHAPTER 54: BIOLOGICAL RESPONSE–MODIFYING DRUGS AND ANTIRHEUMATIC DRUGS .................... 293
CHAPTER 55: ANEMIA DRUGS................................................................................................................... 299
CHAPTER 56: DERMATOLOGICAL DRUGS ................................................................................................. 305
CHAPTER 57: OPHTHALMIC DRUGS .......................................................................................................... 311
CHAPTER 58: OTIC DRUGS......................................................................................................................... 317
, CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY
MULTIPLE CHOICE
1. WHICH IS A JUDGEMENT ABOUT A PARTICULAR PATIENT’S POTENTIAL NEED OR PROBLEM?
A. A GOAL
B. AN ASSESSMENT
C. SUBJECTIVE DATA
D. A NURSING DIAGNOSIS
ANS:D
NURSING DIAGNOSIS IS THE PHASE OF THE NURSING PROCESS DURING WHICH A CLINICAL JUDGEMENT
IS MADE ABOUT HOW A PATIENT RESPONDS TO HEATH CONDITIONS AND LIFE PROCESSES OR
VULNERABILITY FOR THAT RESPONSE.
DIF: COGNITIVE LEVEL: KNOWLEDGE
2. THE PATIENT IS TO RECEIVE ORAL FUROSEMIDE (LASIX) EVERY DAY; HOWEVER, BECAUSE THE
PATIENT IS UNABLE TO SWALLOW, HE CANNOT TAKE MEDICATION ORALLY, AS ORDERED. THE NURSE
NEEDS TO CONTACT THE PHYSICIAN. WHAT TYPE OF PROBLEM IS THIS?
A. A “RIGHT TIME” PROBLEM
B. A “RIGHT DOSE” PROBLEM
C. A “RIGHT ROUTE” PROBLEM
D. A “RIGHT MEDICATION” PROBLEM
ANS:C
THIS IS A “RIGHT ROUTE” PROBLEM: THE NURSE CANNOT ASSUME THE ROUTE AND MUST CLARIFY THE
ROUTE WITH THE PRESCRIBER. THIS IS NOT A “RIGHT TIME” PROBLEM BECAUSE THE ORDERED
FREQUENCY HAS NOT CHANGED. THIS IS NOT A “RIGHT DOSE” PROBLEM BECAUSE THE DOSE IS NOT
RELATED TO AN INABILITY TO SWALLOW. THIS IS NOT A “RIGHT MEDICATION” PROBLEM BECAUSE THE
MEDICATION ORDERED WILL NOT CHANGE, JUST THE ROUTE.
DIF: COGNITIVE LEVEL: APPLICATION
